SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-268939
Filing Date
2023-11-02
Accepted
2023-11-02 09:10:59
Documents
14
Period of Report
2023-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d554165d8k.htm   iXBRL 8-K 32568
2 EX-99.1 d554165dex991.htm EX-99.1 23637
6 GRAPHIC g554165g1102013340338.jpg GRAPHIC 2525
  Complete submission text file 0001193125-23-268939.txt   196049

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20231102.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20231102_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20231102_pre.xml EX-101.PRE 11708
8 EXTRACTED XBRL INSTANCE DOCUMENT d554165d8k_htm.xml XML 3468
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 231370341
SIC: 2836 Biological Products, (No Diagnostic Substances)